Five Prime Therapeutics, Inc. Form DEFA14A: Additional definitive proxy soliciting materials
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2020-04-22: Form DEFA14A; Description DEFA14A; Document fprx-defa14a_20200514.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2020-04-22 | DEFA14A | DEFA14A | fprx-defa14a_20200514.htm |